Impact of Daily Prophylaxis Dose Anticoagulation with a Factor Xa Inhibitor (Apixaban) in Patients with Sickle Cell Disease

Administered By

Awarded By

Contributors

Start/End

  • December 1, 2013 - November 30, 2016